SCHEMBL21147852

SCHEMBL21147852

c1ccc(-c2ccc(-n3c4ccccc4c4ccccc43)c(-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccc(-c6ccccc6)c(-n6c7ccccc7c7ccccc76)c5)n4)cc3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.37
KDM4E B2RXH2 4/20 0.37
ATM Q13315 3/20 0.37
ACP1 P24666 2/20 0.36
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
MAPT P10636 3/20 0.35
NPSR1 Q6W5P4 2/20 0.33
STAT6 P42226 1/20 0.33
LMNA P02545 3/20 0.33
APAF1 O14727 1/20 0.33
NPC1 O15118 1/20 0.33
THRB P10828 1/20 0.33
XBP1 P17861 1/20 0.33
PTBP1 P26599 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
GALK1 P51570 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21147345 0.99 KDM4E (0.38) L3MBTL1KDM4EATMACP1MEN1
SCHEMBL21147318 0.97 KDM4E (0.35) L3MBTL1KDM4EATMACP1MEN1
SCHEMBL21147142 0.97 KDM4E (0.35) L3MBTL1KDM4EATMACP1MEN1
SCHEMBL21147822 0.97 KDM4E (0.35) L3MBTL1KDM4EATMACP1MEN1
SCHEMBL21147380 0.97 KDM4E (0.35) L3MBTL1KDM4EATMACP1MEN1
SCHEMBL21147529 0.97 L3MBTL1 (0.35) L3MBTL1KDM4EATMACP1MEN1
SCHEMBL21147192 0.97 KDM4E (0.35) L3MBTL1KDM4EATMACP1MEN1
SCHEMBL21147352 0.97 KDM4E (0.35) L3MBTL1KDM4EATMACP1MEN1
SCHEMBL21147252 0.97 KDM4E (0.39) L3MBTL1KDM4EATMACP1MEN1
SCHEMBL21147383 0.96 L3MBTL1 (0.36) L3MBTL1KDM4EATMACP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-20200212314-A1 ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 US disclosed
EP-3675194-A1 ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME Samsung Electronics Co., Ltd. (KR) 2020-07-01 EP disclosed
US-20190214570-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CRY1, CYP1B1, CYP1A1 L3MBTL1 1990/4885KDM4E 2739/4885ATM 2932/4885
US-20190214570-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND CRY1, CYP1B1, CYP1A1 L3MBTL1 1990/4885KDM4E 2739/4885ATM 2932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.